The WWTR1 gene helps control when cells grow, divide, and mature, especially as tissues develop and repair themselves. This gene plays an important role in helping cells respond to physical signals from their surroundings, such as how crowded or stretched a tissue is. If the gene does not work properly, cell growth can become less controlled or normal tissue development can be disrupted. Some variants in the WWTR1 gene are linked to inherited eye conditions that affect the retina, the light sensing tissue at the back of the eye, and abnormal activity of this gene may also play a role in some cancers.
What is a gene?
Genes are sections of DNA that provide instructions your cells can use to make molecules or guide processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
WWTR1Gene function
What if the gene works
The WWTR1 gene helps control which genes cells turn on as tissues grow, renew, and repair. It works in a cell signaling pathway that helps guide cell growth, movement, and organ development.
Risk
What if the gene does not work
Changes in the WWTR1 gene can range from milder to more severe and may reduce how well cells relay Hippo pathway signals. This can weaken gene control programs that guide cell growth, tissue repair, and organ development.
Treatment
What does that mean for your treatment
No WWTR1-specific treatment or management approach is currently established for pathogenic variants in the WWTR1 gene. The WWTR1 gene is being studied as a biomarker and possible drug target in some cancers, where altered WWTR1 activity may affect cell growth and response to treatment.
Conditions associated with WWTR1
Gene function
What if the gene works
The WWTR1 gene helps cells sense their surroundings and adjust which genes are active. Its protein, often called TAZ, acts like a messenger between outside cues and the cell’s instruction manual. This is central to how the WWTR1 gene works in the Hippo pathway, a cell system that helps coordinate normal growth and tissue upkeep.
The WWTR1 gene helps turn specific genes on by partnering with TEAD proteins, which help read DNA instructions. This lets cells carry out planned programs for growth, repair, and everyday tissue upkeep.
Its protein passes along messages about cell crowding, attachment, and physical tension in a tissue. This helps cells match growth and survival to local conditions instead of acting in isolation.
When cells feel stretch or pressure, WWTR1 helps translate those mechanical cues into changes in gene activity. This supports organized tissue structure during development and routine renewal.
WWTR1 also helps guide how less specialized cells choose and maintain their roles. This supports steady tissue renewal in places where cells are regularly replaced.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can affect how a gene works more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the WWTR1 gene can change how stable the TAZ protein is, how well it binds partner proteins, and whether it reaches the cell nucleus where it helps control gene activity. In practical terms, how variants influence the WWTR1 gene's function depends on the change: milder variants may partly weaken protein activity, while more severe variants can disrupt key binding sites, alter protein shape, or leave little to no working protein in the cell.
How variants are linked to conditions
Changes involving the WWTR1 gene are most clearly linked to epithelioid hemangioendothelioma, a rare tumor, especially when a WWTR1 gene fusion in epithelioid hemangioendothelioma is found as WWTR1::CAMTA1. This kind of change is usually present only in the tumor and can help confirm the diagnosis rather than predict inherited risk.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the WWTR1 gene. Risk can vary depending on the exact genetic change and the health condition being considered, so personal history and family history still matter. Anyone concerned about their own risk should speak with a doctor or genetic counselor.
Inheritance of WWTR1 variants
There is not yet a broadly confirmed, disease specific WWTR1 inheritance pattern for inherited conditions tied to the WWTR1 gene, though this can become clearer as research develops. WWTR1 is on chromosome 3, which is an autosome, so you inherit one copy of the WWTR1 gene from each parent. In general, that means any inherited variant in this gene could be passed through either side of the family rather than following an X linked or mitochondrial pattern.
What does my WWTR1 result mean for my family?
There isn't yet a broadly confirmed inherited pattern tied to a specific health condition for the WWTR1 gene, though this can change as research develops. If you have a specific WWTR1 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your result and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the WWTR1 gene usually uses a blood or saliva sample. A lab reads the DNA sequence of the WWTR1 gene, often as part of a multigene panel or exome test, and compares it with the usual sequence. Results may show no variant, a benign variant, or a variant that may help explain a diagnosis.
When should I consider getting a genetic test?
There is not yet a broadly established, WWTR1-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health, family history, and whether a doctor or genetic counselor thinks a broader gene panel could help answer a specific medical question.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although what it can tell you varies with the condition and the specific type of variant. Over time, the body is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. For areas like medication response, genetic results may help put a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or how strongly the drug acts on its target. This kind of variation is common and helps explain why the same treatment works well for some people, has less effect in others, or can cause more side effects in certain people.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences shape a person’s response to medicines. By studying links between genes and medications, it helps explain why the same treatment may affect people in different ways. For many drugs, genes can influence how powerfully a medicine works or how the body handles it. That information can support treatment choices that are better informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the WWTR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so general health or medication concerns are best discussed with your doctor. Seek medical advice if you develop troublesome side effects, a new rash, breathing trouble, chest pain, or swelling after starting or changing a medicine.
History
WWTR1 entered the scientific literature in the late 1990s, when researchers identified it under the name TAZ during work on proteins that influence gene activity. It was later recognized as WWTR1, and its place in a broader cell growth signaling network became clearer in the early 2000s. Building on this early work, scientists found that WWTR1 drew particular interest in cancer research because of recurrent gene fusions seen in some rare tumors. A major step came when the WWTR1-CAMTA1 fusion was linked to epithelioid hemangioendothelioma, helping define that condition more precisely. Over time, WWTR1 became known less as an isolated discovery and more as part of a larger shift in how researchers understand growth control and tumor biology.